Literature DB >> 31522411

Immunophenotyping by Mass Cytometry.

Gregory K Behbehani1.   

Abstract

Mass cytometry is a novel technology similar to flow cytometry in which antibodies are tagged with heavy metal molecules rather than fluorophores and then detected with time-of-flight mass spectrometry. This enables measurement of up to 50 simultaneous parameters with no autofluorescent background and little or no spillover or required compensation. Mass cytometry has tremendous potential for the analysis of highly complex research or clinical samples and can measure 40-50 immunophenotypic markers at a time. This chapter describes most of the commonly used methods for performing basic immunophenotyping experiments by mass cytometry, and how this can be combined with measurement of cellular functional properties.

Entities:  

Keywords:  Aberrant marker expression; Acute leukemia; CyTOF; Flow cytometry; Immunophenotyping; Mass cytometry; Minimal residual disease

Mesh:

Substances:

Year:  2019        PMID: 31522411     DOI: 10.1007/978-1-4939-9650-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.

Authors:  Swagata Goswami; Rajeswaran Mani; Jessica Nunes; Chi-Ling Chiang; Kevan Zapolnik; Eileen Hu; Frank Frissora; Xiaokui Mo; Logan A Walker; Pearlly Yan; Ralf Bundschuh; Larry Beaver; Raymond Devine; Yo-Ting Tsai; Ann Ventura; Zhiliang Xie; Min Chen; Rosa Lapalombella; Alison Walker; Alice Mims; Karilyn Larkin; Nicole Grieselhuber; Chad Bennett; Mitch Phelps; Erin Hertlein; Gregory Behbehani; Sumithira Vasu; John C Byrd; Natarajan Muthusamy
Journal:  Blood       Date:  2022-03-03       Impact factor: 25.476

2.  Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation.

Authors:  Irene Sarkar; Richard Davies; Anders K Aarebrot; Silje M Solberg; Aleksandra Petrovic; Anagha M Joshi; Brith Bergum; Johan G Brun; Daniel Hammenfors; Roland Jonsson; Silke Appel
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

3.  Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming.

Authors:  Hongji Zhang; Tianmeng Chen; Jinghua Ren; Yujia Xia; Amblessed Onuma; Yu Wang; Jiayi He; Junru Wu; Han Wang; Ahmad Hamad; Chengli Shen; Jinxiang Zhang; John M Asara; Gregory K Behbehani; Haitao Wen; Meihong Deng; Allan Tsung; Hai Huang
Journal:  Nat Metab       Date:  2021-06-14

Review 4.  Current Challenges in Vaccinology.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Peter Palese; Gregory A Poland
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

Review 5.  Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.

Authors:  Laura Bracci; Alessandra Fragale; Lucia Gabriele; Federica Moschella
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

6.  Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia.

Authors:  Susanne Gonder; Iria Fernandez Botana; Marina Wierz; Giulia Pagano; Ernesto Gargiulo; Antonio Cosma; Etienne Moussay; Jerome Paggetti; Anne Largeot
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.